Phase Ia/II, two-arm, open-label, dose-escalation study of oral panobinostat administered via two dosing schedules in patients with advanced hematologic malignancies.

Autor: DeAngelo, D J1, Spencer, A2, Bhalla, K N3, Prince, H M4, Fischer, T5, Kindler, T6, Giles, F J7, Scott, J W8, Parker, K8, Liu, A8, Woo, M8, Atadja, P8, Mishra, K K8, Ottmann, O G9
Zdroj: Leukemia (08876924). Aug2013, Vol. 27 Issue 8, p1628-1636. 9p. 1 Diagram, 6 Charts, 1 Graph.
Databáze: Academic Search Ultimate